Identification of SUMOylation modifiers involved in lung adenocarcinoma progression and Osimertinib resistance by integrated bioinformatics analysis.

Documenti analoghi

• BIT1 as an Effector of EGFR-TKI-induced Apoptosis TLE1 Inhibition in Lung Adenocarcinoma Cells.
  di: Dela Cruz, Ma Carmela, et al.
  Pubblicazione: (2026)
• FOXR2 in cancer development: emerging player and therapeutic opportunities.
  di: Yang, Piao, et al.
  Pubblicazione: (2025)
• Natural compounds as regulators of miRNAs: exploring a new avenue for treating colorectal cancer.
  di: Doghish, Ahmed S, et al.
  Pubblicazione: (2025)
• MSR1 in lung squamous cell carcinoma: Prognostic and immunological values in pan-cancer and single-cell analyses and a cohort study.
  di: Bu, Yuxiang, et al.
  Pubblicazione: (2025)
• KDM5C: A dual-edged epigenetic regulator in cancer biology-context-dependent roles and therapeutic implications.
  di: Tu, Fei-Yang, et al.
  Pubblicazione: (2025)